Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
about
Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse EffectsSelective ruthenium labeling of the tryptophan residue in the bee venom Peptide melittinPerfluorocarbon nanoparticles for physiological and molecular imaging and therapyPerfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic propertiesSynthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening.Preparation, characterization, in vitro release and degradation of cathelicidin-BF-30-PLGA microspheres.Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity.Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formersPeptide delivery using phospholipid micelles.Nanotherapeutic strategies for the treatment of Alzheimer's disease.Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.Application of bee venom and its main constituent melittin for cancer treatment.Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.Using Multifunctional Peptide Conjugated Au Nanorods for Monitoring β-amyloid Aggregation and Chemo-Photothermal Treatment of Alzheimer's Disease.Dual secured nano-melittin for the safe and effective eradication of cancer cells.Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease.Analysis of cytotoxicity of melittin on adherent culture of human endothelial cells reveals advantage of fluorescence microscopy over flow cytometry and haemocytometer assay.Melittin, a Potential Natural Toxin of Crude Bee Venom: Probable Future Arsenal in the Treatment of Diabetes Mellitus
P2860
Q26749090-9593F88D-87C5-46A2-A797-4D82554BC434Q27698009-1607D756-A30F-4DF6-9DFF-F5FA746C4769Q30426880-60813647-E210-4366-8D5F-59D8B3B56FFFQ33760320-AE2A4E22-B5D6-467A-9FE0-B17BA4B160E2Q34581262-5C0B72BD-FBF2-43B3-85A4-1A53399EA241Q35194563-ADFD0A36-9CB6-4E17-85F7-47D69BDFFC7EQ35859779-FA2335C4-4872-4941-A4BB-DFF8B9E7B0AAQ36191769-D474786C-7D27-4D2D-B1F0-63EB9341F68BQ38030889-6B498524-E30C-4449-8CF7-F3808E42645AQ38358865-70021F19-57BF-494B-962C-29C14D233D23Q38401839-DB10DBA9-8AB2-4168-A889-66627718167FQ38413846-EDF07043-1F17-4C9F-B9BF-D3CCDF02D8FBQ38768426-C8255C30-FD4A-4C4D-9998-65923388CF15Q38966140-FBC1AD36-C4B1-4C0F-B38F-3CB54AE4790CQ39673726-84DF593D-6A65-431D-B205-BBD37C3AAC18Q41481527-C360C5F8-76BA-45E2-943B-E00038DAF72AQ42583845-6C758D36-0CBF-45A0-B40E-A09E18EE37BDQ46466132-474F5DA0-CCAF-4626-B18F-B6143A07AC1DQ50236548-0346A824-0E2A-4165-AFF5-92B52A183ED4Q58669216-FFE8E779-06CE-4581-A4E7-F85CBE68EE6A
P2860
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
@en
Cytolytic peptide nanoparticles
@nl
type
label
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
@en
Cytolytic peptide nanoparticles
@nl
prefLabel
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
@en
Cytolytic peptide nanoparticles
@nl
P2093
P2860
P356
P1476
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
@en
P2093
Gregory M Lanza
Neelesh R Soman
Paul H Schlesinger
Samuel A Wickline
P2860
P304
P356
10.1002/WNAN.126
P577
2011-01-10T00:00:00Z